The ARLG Fellowship is up to two-years, fully funded, competitive opportunity to acquire expertise in antibacterial resistance clinical research. The ARLG Fellowship is designed for infectious disease fellows interested in pursuing research, training, and a subsequent career in the patient-oriented study of antibiotic resistance. Recipients will be integrated into the ARLG mission and programs.
Recipients of the award will receive:
- Salary for two years of ID fellowship.
- Mentoring in antibacterial resistance research.
- Formal training in epidemiology or statistics at the Duke Clinical Research Institute, Duke Clinical Research Training Program, or an equivalent program at another institution. Costs for this epidemiology and statistics coursework will be paid by the ARLG.
- Mentoring from senior mentors who are part of the ARLG.
- US Citizen or non-citizen nationals, or individuals lawfully admitted for permanent residence.
- Infectious disease fellow.
Application and Selection Process
Applicants who are interested in the ARLG Fellow position are required to submit the following:
- Application form.
- Applicant’s NIH biosketch.
- Mentor’s NIH Biosketch and Letter of Support.
- Letters of recommendation (3 are required).
- ARLG Fellowship proposal: Please include the following sections as part of the proposal:
Candidate background, goals and objectives (1-2 pages)
- Describe the candidate's commitment to an academic career studying antibiotic resistance consistent with the ARLG mission and goals.
- Provide evidence of the candidate's potential to develop into an independent investigator in antibiotic resistance.
- Describe the candidates short term and long term academic goals
Candidate's Plan for Career Development/Training Activities during Award Period (1-2 pages)
- The career development/training activities plan during the award period will depend greatly on the candidate’s background. We expect the plan to vary from application to application.
- The candidate and the mentor are jointly responsible for the preparation of the career development plan. A timeline is often helpful. The mentor, in consultation with the applicant, may form a mentoring team (or an advisory committee) to assist with the development of the program of study or to monitor the candidate's progress through the career development program.
- The didactic (if any) and the research aspects of the plan must be designed to develop the necessary knowledge and research skills in scientific areas relevant to the candidate's career goals. The candidate must demonstrate they have received training or will participate in courses that will help them achieve their short term and long term academic goals.
- It is mandatory that applicants include some planned coursework or completed coursework demonstrating proficiency in clinical research in epidemiology and statistics that are part of traditional MS or MPH coursework. This coursework must allow the researcher to be an expert in patient-oriented research in antibiotic resistance. Examples include coursework in clinical trials, cohort design, case-control design. Epidemiology skills, and statistics skills in these areas are required.
Research plan: (3-4 pages)
Describe the research plan proposed. The research should address a US antimicrobial resistance problem consistent with the ARLG mission. The research plan should include sections on specific aims, hypotheses, methods, limitations/potential pitfalls and timeline. Describe how the research project will be funded.
Integration into the ARLG (1 page)
Applicants will describe how they plan to integrate themselves into the ARLG mission, operations and programs. This section will be based on their review of the ARLG website that describes activities and current projects of the ARLG.
The ARLG Mentoring Committee will review submissions and provide recommendations to the Executive Committee. The Executive Committee will make the final decision regarding selection of the ARLG Fellow.
“ARLG is not merely a funding mechanism; rather, it is a community of scientists who ardently pursue improved human health through a better understanding of the optimal prevention, detection, and management of antimicrobial resistance.”
Judith A. Anesi, MD
University of Pennsylvania Perelman School of Medicine